NECT,CETの放射性および臨床特性を用いて,進行したEGFR変異性肺腺がん患者のPD- L1発現を予測する
Jinjin Li1, Ziyi Yang1,2, Liangzhong Liu1
1Department of Cancer Center, The Second Affiliated Hospital of Chongqing Medical University, No. 288 Tianwen Road, Nan'an District, Chongqing, 400016, China.
BMC cancer
|January 4, 2026
まとめ
No abstract available in PubMed .
さらに関連する動画
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
11.0K
05:17Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
307
